Where Will CRISPR Therapeutics Be in 10 Years?

CRISPR Therapeutics (NASDAQ: CRSP) is about as early as you can get with early-stage biotechs. The company began its first clinical study only a few months ago. There are multiple paths that could unfold based on how this study and others progress.